These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 17359969)
1. Antisense targeting of TGF-beta1 augments BMP-induced upregulation of osteopontin, type I collagen and Cbfa1 in human Saos-2 cells. Shen ZJ; Kim SK; Jun DY; Park W; Kim YH; Malter JS; Moon BJ Exp Cell Res; 2007 Apr; 313(7):1415-25. PubMed ID: 17359969 [TBL] [Abstract][Full Text] [Related]
2. Bone morphogenetic protein-3b (BMP-3b) inhibits osteoblast differentiation via Smad2/3 pathway by counteracting Smad1/5/8 signaling. Matsumoto Y; Otsuka F; Hino J; Miyoshi T; Takano M; Miyazato M; Makino H; Kangawa K Mol Cell Endocrinol; 2012 Mar; 350(1):78-86. PubMed ID: 22155034 [TBL] [Abstract][Full Text] [Related]
3. Bone morphogenetic protein activities are enhanced by 3',5'-cyclic adenosine monophosphate through suppression of Smad6 expression in osteoprogenitor cells. Sugama R; Koike T; Imai Y; Nomura-Furuwatari C; Takaoka K Bone; 2006 Feb; 38(2):206-14. PubMed ID: 16203197 [TBL] [Abstract][Full Text] [Related]
4. Differential effects of the Ski-interacting protein (SKIP) on differentiation induced by transforming growth factor-beta1 and bone morphogenetic protein-2 in C2C12 cells. Figueroa JD; Hayman MJ Exp Cell Res; 2004 Jun; 296(2):163-72. PubMed ID: 15149847 [TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta1 downregulation of Smad1 gene expression in rat hepatic stellate cells. Shen H; Huang G; Hadi M; Choy P; Zhang M; Minuk GY; Chen Y; Gong Y Am J Physiol Gastrointest Liver Physiol; 2003 Sep; 285(3):G539-46. PubMed ID: 12791600 [TBL] [Abstract][Full Text] [Related]
6. A road map toward defining the role of Smad signaling in hematopoietic stem cells. Utsugisawa T; Moody JL; Aspling M; Nilsson E; Carlsson L; Karlsson S Stem Cells; 2006 Apr; 24(4):1128-36. PubMed ID: 16357343 [TBL] [Abstract][Full Text] [Related]
7. Differential regulation of osteoadherin (OSAD) by TGF-beta1 and BMP-2. Rehn AP; Chalk AM; Wendel M Biochem Biophys Res Commun; 2006 Oct; 349(3):1057-64. PubMed ID: 16970923 [TBL] [Abstract][Full Text] [Related]
8. Regulation of Notch signaling genes during BMP2-induced differentiation of osteoblast precursor cells. de Jong DS; Steegenga WT; Hendriks JM; van Zoelen EJ; Olijve W; Dechering KJ Biochem Biophys Res Commun; 2004 Jul; 320(1):100-7. PubMed ID: 15207708 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of histone deacetylase activity suppresses epithelial-to-mesenchymal transition induced by TGF-beta1 in human renal epithelial cells. Yoshikawa M; Hishikawa K; Marumo T; Fujita T J Am Soc Nephrol; 2007 Jan; 18(1):58-65. PubMed ID: 17135397 [TBL] [Abstract][Full Text] [Related]
10. Dexamethasone modulates BMP-2 effects on mesenchymal stem cells in vitro. Jäger M; Fischer J; Dohrn W; Li X; Ayers DC; Czibere A; Prall WC; Lensing-Höhn S; Krauspe R J Orthop Res; 2008 Nov; 26(11):1440-8. PubMed ID: 18404732 [TBL] [Abstract][Full Text] [Related]
12. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway. Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456 [TBL] [Abstract][Full Text] [Related]
13. Mitogen activated protein kinase-dependent inhibition of osteocalcin gene expression by transforming growth factor-beta1. Kwok S; Partridge NC; Srinivasan N; Nair SV; Selvamurugan N J Cell Biochem; 2009 Jan; 106(1):161-9. PubMed ID: 19051235 [TBL] [Abstract][Full Text] [Related]
14. Characterization of SIS3, a novel specific inhibitor of Smad3, and its effect on transforming growth factor-beta1-induced extracellular matrix expression. Jinnin M; Ihn H; Tamaki K Mol Pharmacol; 2006 Feb; 69(2):597-607. PubMed ID: 16288083 [TBL] [Abstract][Full Text] [Related]
15. Osteoblasts-derived BMP-2 enhances the motility of prostate cancer cells via activation of integrins. Lai TH; Fong YC; Fu WM; Yang RS; Tang CH Prostate; 2008 Sep; 68(12):1341-53. PubMed ID: 18512729 [TBL] [Abstract][Full Text] [Related]
16. Expression of bone morphogenic protein 2/4, transforming growth factor-beta1, and bone matrix protein expression in healing area between vascular tibia grafts and irradiated bone-experimental model of osteonecrosis. Schultze-Mosgau S; Lehner B; Rödel F; Wehrhan F; Amann K; Kopp J; Thorwarth M; Nkenke E; Grabenbauer G Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1189-96. PubMed ID: 15752901 [TBL] [Abstract][Full Text] [Related]
17. Bone morphogenic protein-7 inhibits monocyte-stimulated TGF-beta1 generation in renal proximal tubular epithelial cells. Zhang XL; Selbi W; de la Motte C; Hascall V; Phillips AO J Am Soc Nephrol; 2005 Jan; 16(1):79-89. PubMed ID: 15574511 [TBL] [Abstract][Full Text] [Related]
18. Enhanced bone formation by transforming growth factor-beta1-releasing collagen/chitosan microgranules. Lee JY; Kim KH; Shin SY; Rhyu IC; Lee YM; Park YJ; Chung CP; Lee SJ J Biomed Mater Res A; 2006 Mar; 76(3):530-9. PubMed ID: 16331652 [TBL] [Abstract][Full Text] [Related]
19. Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts. Tang CH; Yang RS; Chien MY; Chen CC; Fu WM Eur J Pharmacol; 2008 Jan; 579(1-3):40-9. PubMed ID: 17980360 [TBL] [Abstract][Full Text] [Related]
20. Chondrogenic differentiation of human mesenchymal stem cells in collagen type I hydrogels. Nöth U; Rackwitz L; Heymer A; Weber M; Baumann B; Steinert A; Schütze N; Jakob F; Eulert J J Biomed Mater Res A; 2007 Dec; 83(3):626-35. PubMed ID: 17503531 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]